We, therefore, propose that elevation in intracellular FOXO3 levels, as particularly evident for FOXO3 G-allele carriers (22), may protect against progressive injuries to the coronary arteries of individuals with chronic hypertension, thereby protecting them from CAD-associated clinical manifestations. This evidence concerns the gene FOXO3 and coronary artery disorder.